Heart Failure and Major Adverse Cardiovascular Events in Atrial Fibrillation Patients: A Retrospective Primary Care Cohort Study

被引:6
|
作者
Molto-Balado, P. [1 ,2 ]
Reverte-Villarroya, S. [3 ]
Monclus-Arasa, C. [1 ]
Balado-Albiol, M. T. [4 ]
Baset-Martinez, S. [5 ]
Carot-Domenech, J. [6 ]
Clua-Espuny, J. L. [7 ,8 ]
机构
[1] Inst Catala Salut, Primary Hlth Care Ctr Tortosa Oest, Primary Care Serv SAP Terres Ebre, Tortosa 43500, Spain
[2] Univ Rovira & Virgili, Biomed Doctoral Programme, Tortosa 43500, Spain
[3] Univ Rovira & Virgili, Nursing Dept, Biomed Doctoral Programme, Adv Nursing Res Grp, Campus Terres Ebre, Tortosa 43500, Spain
[4] Primary Hlth Care Ctr CS Burriana I, Dept Salut La Plana, Conselleria Sanitat, Burriana 12540, Spain
[5] Inst Catala Salut, Nusing Management Primary Hlth Care Ctr Tortosa Es, Primary Care Serv SAP Terres Ebre, Tortosa 43500, Spain
[6] Inst Catala Salut, Direct Informat & Commun Syst, Terr Management Terres Ebre, Tortosa 43500, Spain
[7] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Res Support Unit Terres Ebre, Ebrictus Res Grp, Tortosa 43500, Spain
[8] Inst Catala Salut, Primary Hlth Care Ctr Tortosa Est, Primary Care Serv SAP Terres Ebre, Toosa 43500, Spain
关键词
atrial fibrillation; risk-atrial fibrillation; heart failure; outcomes; major adverse cardiovascular events (MACE); major outcomes; vascular events; primary health care; CHRONIC KIDNEY-DISEASE; RISK; MORTALITY; OUTCOMES; COVID-19; SCORE;
D O I
10.3390/biomedicines11071825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Atrial fibrillation (AF) is a common cardiac arrhythmia that is associated with an increased risk of major adverse cardiovascular events (MACE). The main goal was to analyze the links and associations between AF and MACE. Methods: A multicenter, observational, retrospective, community-based study of a cohort (n = 40,297) of the general population aged 65-95 years between 1 January 2015 and 31 December 2021 without a previous diagnosis of AF or MACE in the Primary Care setting. Results: 2574 people (6.39%) developed a first AF event, resulting in an overall incidence of 8.9/1000 people-years [CI95% 8.6-9.2]. The incidence of MACE among those with AF was 75.1/1000 people-years [CI95% 70.8-79.5], whereas among those without AF, it was 20.6/1000 people-years [CI 95% 20.2-21.1], resulting in a rate ratio of 3.65 [CI 95% 3.43-3.88, p < 0.001]. Besides, the incidence of HF with AF was 40.1 people-years [CI 95% 37.1-43.2], while in the group without AF, it was 8.3 people-years [CI 95% 7.9-8.6, p < 0.001], with a rate ratio of 4.85 [CI 95% 4.45-55.3, p < 0.001]. Before an AF diagnosis, there is already a higher risk of chronic kidney disease, ischemic cardiopathy, and peripheral artery disease. A higher risk of poor nutritional status was detected among those with MACE (49.7% vs. 26.6%, p < 0.001). Conclusions: AF diagnosis increases the incidence of heart failure fourfold. Additional information is required to establish the connection between AF, major adverse cardiovascular events, and nutritional status.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation: a cohort study in primary care
    Wandell, Per
    Carlsson, Axel C.
    Holzmann, Martin J.
    Arnlov, Johan
    Sundquist, Jan
    Sundquist, Kristina
    JOURNAL OF HYPERTENSION, 2018, 36 (09) : 1929 - 1935
  • [2] Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
    Miao, Benjamin
    Hernandez, Adrian V.
    Roman, Yuani M.
    Alberts, Mark J.
    Coleman, Craig I.
    Baker, William L.
    CLINICAL CARDIOLOGY, 2020, 43 (05) : 524 - 531
  • [3] Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation
    Iten, Vasco
    Herber, Elena
    Coslovsky, Michael
    Hennings, Elisa
    Paladini, Rebecca E.
    Reichlin, Tobias
    Rodondi, Nicolas
    Mueller, Andreas S.
    Stauber, Annina
    Beer, Juerg H.
    Brenner, Roman
    Conte, Giulio
    Kobza, Richard
    Di Valentino, Marcello
    Bedoya, Patricia Chocano
    Moradi, Freschteh
    Sinnecker, Tim
    Bonati, Leo H.
    Kuehne, Michael
    Osswald, Stefan
    Conen, David
    Aeschbacher, Stefanie
    Zuern, Christine S.
    BMC MEDICINE, 2024, 22 (01):
  • [4] Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation
    Kwon, Chang Hee
    Kim, Ye-Jee
    Kim, Min-Ju
    Cha, Myung-Jin
    Cho, Min Soo
    Nam, Gi-Byoung
    Choi, Kee-Joon
    Kim, Jun
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 178 : 35 - 42
  • [5] Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
    Cutler, Michael J.
    May, Heidi T.
    Bair, Tami L.
    Crandall, Brian G.
    Osborn, Jeffrey S.
    Miller, Jared D.
    Mallender, Charles D.
    Muhlestein, Joseph B.
    Anderson, Jeffrey L.
    Knowlton, Kirk U.
    Knight, Stacey
    IJC HEART & VASCULATURE, 2022, 43
  • [6] Proteinuria is independently associated with heart failure events in patients with atrial fibrillation: the Fushimi AF registry
    Ikeda, Syuhei
    An, Yoshimori
    Iguchi, Moritake
    Ogawa, Hisashi
    Nakanishi, Yumiko
    Minami, Kimihito
    Ishigami, Kenjiro
    Aono, Yuya
    Doi, Kosuke
    Hamatani, Yasuhiro
    Yoshizawa, Takashi
    Ide, Yuya
    Fujino, Akiko
    Ishii, Mitsuru
    Masunaga, Nobutoyo
    Esato, Masahiro
    Tsuji, Hikari
    Wada, Hiromichi
    Hasegawa, Koji
    Abe, Mitsuru
    Akao, Masaharu
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 9 (08) : 758 - 767
  • [7] Presence of Atrial Fibrillation Is Independently Associated With Adverse Outcomes in Patients Hospitalized With Heart Failure An Analysis of Get With The Guidelines-Heart Failure
    Mountantonakis, Stavros E.
    Grau-Sepulveda, Maria V.
    Bhatt, Deepak L.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Fonarow, Gregg C.
    CIRCULATION-HEART FAILURE, 2012, 5 (02) : 191 - U158
  • [8] Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East
    AI-Zakwani, Ibrahim
    Panduranga, P.
    Zubaid, M.
    Sulaiman, K.
    Rashed, W. A.
    Alsheikh-Ali, A. A.
    AlMahmeed, W.
    Shehab, A.
    Al Qudaimi, A.
    Asaad, N.
    Amin, H.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 21 (03) : 273 - 279
  • [9] Development and validation of a nomogram for predicting atrial fibrillation in patients with acute heart failure admitted to the ICU: a retrospective cohort study
    Li, Yide
    Cai, Zhixiong
    She, Yingfang
    Shen, Wenjuan
    Wang, Tinghuai
    Luo, Liang
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [10] Machine Learning Approaches to Predict Major Adverse Cardiovascular Events in Atrial Fibrillation
    Molto-Balado, Pedro
    Reverte-Villarroya, Silvia
    Alonso-Barberan, Victor
    Monclus-Arasa, Cinta
    Balado-Albiol, Maria Teresa
    Clua-Queralt, Josep
    Clua-Espuny, Josep-Lluis
    TECHNOLOGIES, 2024, 12 (02)